longtext: 3F9C-pdb

content
HEADER    HYDROLASE                               13-NOV-08   3F9C
TITLE     CRYSTAL STRUCTURE OF HUMAN PLASMA PLATELET ACTIVATING FACTOR
TITLE    2 ACETYLHYDROLASE COVALENTLY INHIBITED BY
TITLE    3 DIISOPROPYLFLUOROPHOSPHATE
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE;
COMPND   3 CHAIN: A, B;
COMPND   4 FRAGMENT: UNP RESIDUES 47-429;
COMPND   5 SYNONYM: PAF ACETYLHYDROLASE, PAF 2-ACYLHYDROLASE, LDL-
COMPND   6 ASSOCIATED PHOSPHOLIPASE A2, LDL-PLA(2), 2-ACETYL-1-
COMPND   7 ALKYLGLYCEROPHOSPHOCHOLINE ESTERASE, 1-ALKYL-2-
COMPND   8 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;
COMPND   9 EC: 3.1.1.47;
COMPND  10 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE   3 ORGANISM_COMMON: HUMAN;
SOURCE   4 ORGANISM_TAXID: 9606;
SOURCE   5 GENE: PLA2G7, PAFAH;
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS    PLASMA PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, SECRETED
KEYWDS   2 PROTEIN, ALPHA/BETA-HYDROLASE-FOLD, LDL-BOUND; LIPOPROTEIN
KEYWDS   3 ASSOCIATED PHOSPHOLIPASE A2, LP-PLA2, GROUP VIIA PLA2,
KEYWDS   4 GLYCOPROTEIN, HYDROLASE, LIPID DEGRADATION, POLYMORPHISM,
KEYWDS   5 DIISOPROPYLFLUOROPHOSPHATE, DFP, DISEASE MUTATION, SECRETED
EXPDTA    X-RAY DIFFRACTION
AUTHOR    U.SAMANTA,B.J.BAHNSON
REVDAT   1   23-JUN-09 3F9C    0
JRNL        AUTH   U.SAMANTA,S.D.KIRBY,P.SRINIVASAN,D.M.CERASOLI,
JRNL        AUTH 2 B.J.BAHNSON
JRNL        TITL   CRYSTAL STRUCTURES OF HUMAN GROUP-VIIA
JRNL        TITL 2 PHOSPHOLIPASE A2 INHIBITED BY ORGANOPHOSPHORUS
JRNL        TITL 3 NERVE AGENTS EXHIBIT NON-AGED COMPLEXES.
JRNL        REF    BIOCHEM.PHARM.                             2009
JRNL        REFN                   ISSN 0006-2952
JRNL        PMID   19394314
JRNL        DOI    10.1016/J.BCP.2009.04.018
REMARK   1
REMARK   2
REMARK   2 RESOLUTION.    2.30 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : REFMAC 5.2.0019
REMARK   3   AUTHORS     : MURSHUDOV,VAGIN,DODSON
REMARK   3
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 50.00
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 1.000
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.9
REMARK   3   NUMBER OF REFLECTIONS             : 34789
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.199
REMARK   3   R VALUE            (WORKING SET) : 0.196
REMARK   3   FREE R VALUE                     : 0.261
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000
REMARK   3   FREE R VALUE TEST SET COUNT      : 1826
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 20
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.30
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.36
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 2542
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 99.78
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2450
REMARK   3   BIN FREE R VALUE SET COUNT          : 121
REMARK   3   BIN FREE R VALUE                    : 0.3000
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 5978
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 20
REMARK   3   SOLVENT ATOMS            : 170
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : NULL
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 36.91
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : -1.48000
REMARK   3    B22 (A**2) : 0.56000
REMARK   3    B33 (A**2) : 1.30000
REMARK   3    B12 (A**2) : 0.00000
REMARK   3    B13 (A**2) : 0.46000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.
REMARK   3   ESU BASED ON R VALUE                            (A): 0.358
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.257
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.190
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.754
REMARK   3
REMARK   3 CORRELATION COEFFICIENTS.
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.945
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.911
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  6142 ; 0.020 ; 0.022
REMARK   3   BOND LENGTHS OTHERS               (A):  NULL ;  NULL ;  NULL
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  8301 ; 1.813 ; 1.953
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  NULL ;  NULL ;  NULL
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   739 ; 7.823 ; 5.000
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   295 ;37.302 ;23.966
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):  1061 ;17.355 ;15.000
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    36 ;20.355 ;15.000
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   891 ; 0.119 ; 0.200
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  4654 ; 0.008 ; 0.020
REMARK   3   GENERAL PLANES OTHERS             (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  2823 ; 0.231 ; 0.200
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  4082 ; 0.309 ; 0.200
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):   312 ; 0.167 ; 0.200
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):    54 ; 0.352 ; 0.200
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):     7 ; 0.291 ; 0.200
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  3816 ; 1.058 ; 1.500
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  5944 ; 1.752 ; 2.000
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  2693 ; 2.590 ; 3.000
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  2357 ; 3.825 ; 4.500
REMARK   3
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  NCS RESTRAINTS STATISTICS
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  BULK SOLVENT MODELLING.
REMARK   3   METHOD USED : MASK
REMARK   3   PARAMETERS FOR MASK CALCULATION
REMARK   3   VDW PROBE RADIUS   : 1.40
REMARK   3   ION PROBE RADIUS   : 0.80
REMARK   3   SHRINKAGE RADIUS   : 0.80
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE
REMARK   3  RIDING POSITIONS
REMARK   4
REMARK   4 3F9C COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-08.
REMARK 100 THE RCSB ID CODE IS RCSB050309.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 15-MAY-08
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 6.6
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : N
REMARK 200  RADIATION SOURCE               : ROTATING ANODE
REMARK 200  BEAMLINE                       : NULL
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RUH3R
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.54
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : OSMIC BLUE
REMARK 200
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE
REMARK 200  DETECTOR MANUFACTURER          : RIGAKU
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL2000
REMARK 200  DATA SCALING SOFTWARE          : HKL2000
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 36675
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.300
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 100.0
REMARK 200  DATA REDUNDANCY                : 4.200
REMARK 200  R MERGE                    (I) : 0.06900
REMARK 200  R SYM                      (I) : NULL
REMARK 200   FOR THE DATA SET  : 20.7100
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.38
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.10
REMARK 200  R MERGE FOR SHELL          (I) : 0.44000
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200   FOR SHELL         : 3.230
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP OF CCP4I, REFMAC5 OF CCP4I FOR FINAL
REMARK 200  REFINEMENT
REMARK 200 STARTING MODEL: NATIVE STRUCTURE, PDB ENTRY 3D59
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 48.70
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.6. NATIVE PROTEIN CRYSTAL
REMARK 280  SOAKED IN MOTHER LIQUOR CONTAINING DFP, VAPOR DIFFUSION,
REMARK 280  HANGING DROP, TEMPERATURE 293.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y,-Z
REMARK 290       3555   X+1/2,Y+1/2,Z
REMARK 290       4555   -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       58.18750
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       41.20000
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       58.18750
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       41.20000
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     ALA A    47
REMARK 465     ALA A    48
REMARK 465     ALA A    49
REMARK 465     SER A    50
REMARK 465     PHE A    51
REMARK 465     GLY A    52
REMARK 465     GLN A    53
REMARK 465     ASN A   426
REMARK 465     GLN A   427
REMARK 465     HIS A   428
REMARK 465     ILE A   429
REMARK 465     ALA B    47
REMARK 465     ALA B    48
REMARK 465     ALA B    49
REMARK 465     SER B    50
REMARK 465     PHE B    51
REMARK 465     GLY B    52
REMARK 465     GLN B    53
REMARK 465     GLN B   427
REMARK 465     HIS B   428
REMARK 465     ILE B   429
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION
REMARK 500    HIS A 272   C     SER A 273   N       0.283
REMARK 500    SER A 273   C     PHE A 274   N       0.283
REMARK 500    HIS B 272   C     SER B 273   N       0.301
REMARK 500    SER B 273   C     PHE B 274   N       0.299
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3
REMARK 500    ASP A  73   CB  -  CG  -  OD1 ANGL. DEV. =   5.9 DEGREES
REMARK 500    SER A 273   CA  -  C   -  N   ANGL. DEV. =  23.3 DEGREES
REMARK 500    SER A 273   O   -  C   -  N   ANGL. DEV. = -27.4 DEGREES
REMARK 500    SER B 273   CA  -  C   -  N   ANGL. DEV. =  15.9 DEGREES
REMARK 500    SER B 273   O   -  C   -  N   ANGL. DEV. = -20.4 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ARG A  92      142.71   -171.51
REMARK 500    THR A 113     -148.23   -111.23
REMARK 500    PRO A 131       70.42    -68.88
REMARK 500    ALA A 155     -163.92   -101.60
REMARK 500    LYS A 266       75.42   -114.00
REMARK 500    SER A 273     -105.26     68.63
REMARK 500    SER A 336      134.49   -170.78
REMARK 500    HIS A 399       59.38   -118.54
REMARK 500    LYS A 400     -166.71   -121.25
REMARK 500    THR A 424      114.03    -32.35
REMARK 500    GLN B  88      -61.98    -90.58
REMARK 500    ASN B  90       88.31   -162.07
REMARK 500    THR B 113     -167.02   -107.98
REMARK 500    HIS B 114     -162.24   -109.04
REMARK 500    PRO B 131       65.83    -68.90
REMARK 500    LYS B 266       76.10   -106.74
REMARK 500    SER B 273     -108.16     79.58
REMARK 500    HIS B 399       64.66   -109.85
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500                                 MODEL     OMEGA
REMARK 500 THR B  424     THR B  425                 -130.93
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CHIRAL CENTERS
REMARK 500
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (11X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)
REMARK 500
REMARK 500   M RES CSSEQI    IMPROPER   EXPECTED   FOUND DETAILS
REMARK 500     ASN A 423        24.9      L          L   OUTSIDE RANGE
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFP A 473
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFP B 473
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3D59   RELATED DB: PDB
REMARK 900 THE SAME WILD TYPE PROTEIN
REMARK 900 RELATED ID: 3D5E   RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH PARAOXON
REMARK 900 RELATED ID: 3F96   RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH SARIN
REMARK 900 RELATED ID: 3F97   RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH SOMAN
REMARK 900 RELATED ID: 3F98   RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH TABUN
DBREF  3F9C A   47   429  UNP    Q13093   PAFA_HUMAN      47    429
DBREF  3F9C B   47   429  UNP    Q13093   PAFA_HUMAN      47    429
SEQRES   1 A  383  ALA ALA ALA SER PHE GLY GLN THR LYS ILE PRO ARG GLY
SEQRES   2 A  383  ASN GLY PRO TYR SER VAL GLY CYS THR ASP LEU MET PHE
SEQRES   3 A  383  ASP HIS THR ASN LYS GLY THR PHE LEU ARG LEU TYR TYR
SEQRES   4 A  383  PRO SER GLN ASP ASN ASP ARG LEU ASP THR LEU TRP ILE
SEQRES   5 A  383  PRO ASN LYS GLU TYR PHE TRP GLY LEU SER LYS PHE LEU
SEQRES   6 A  383  GLY THR HIS TRP LEU MET GLY ASN ILE LEU ARG LEU LEU
SEQRES   7 A  383  PHE GLY SER MET THR THR PRO ALA ASN TRP ASN SER PRO
SEQRES   8 A  383  LEU ARG PRO GLY GLU LYS TYR PRO LEU VAL VAL PHE SER
SEQRES   9 A  383  HIS GLY LEU GLY ALA PHE ARG THR LEU TYR SER ALA ILE
SEQRES  10 A  383  GLY ILE ASP LEU ALA SER HIS GLY PHE ILE VAL ALA ALA
SEQRES  11 A  383  VAL GLU HIS ARG ASP ARG SER ALA SER ALA THR TYR TYR
SEQRES  12 A  383  PHE LYS ASP GLN SER ALA ALA GLU ILE GLY ASP LYS SER
SEQRES  13 A  383  TRP LEU TYR LEU ARG THR LEU LYS GLN GLU GLU GLU THR
SEQRES  14 A  383  HIS ILE ARG ASN GLU GLN VAL ARG GLN ARG ALA LYS GLU
SEQRES  15 A  383  CYS SER GLN ALA LEU SER LEU ILE LEU ASP ILE ASP HIS
SEQRES  16 A  383  GLY LYS PRO VAL LYS ASN ALA LEU ASP LEU LYS PHE ASP
SEQRES  17 A  383  MET GLU GLN LEU LYS ASP SER ILE ASP ARG GLU LYS ILE
SEQRES  18 A  383  ALA VAL ILE GLY HIS SER PHE GLY GLY ALA THR VAL ILE
SEQRES  19 A  383  GLN THR LEU SER GLU ASP GLN ARG PHE ARG CYS GLY ILE
SEQRES  20 A  383  ALA LEU ASP ALA TRP MET PHE PRO LEU GLY ASP GLU VAL
SEQRES  21 A  383  TYR SER ARG ILE PRO GLN PRO LEU PHE PHE ILE ASN SER
SEQRES  22 A  383  GLU TYR PHE GLN TYR PRO ALA ASN ILE ILE LYS MET LYS
SEQRES  23 A  383  LYS CYS TYR SER PRO ASP LYS GLU ARG LYS MET ILE THR
SEQRES  24 A  383  ILE ARG GLY SER VAL HIS GLN ASN PHE ALA ASP PHE THR
SEQRES  25 A  383  PHE ALA THR GLY LYS ILE ILE GLY HIS MET LEU LYS LEU
SEQRES  26 A  383  LYS GLY ASP ILE ASP SER ASN VAL ALA ILE ASP LEU SER
SEQRES  27 A  383  ASN LYS ALA SER LEU ALA PHE LEU GLN LYS HIS LEU GLY
SEQRES  28 A  383  LEU HIS LYS ASP PHE ASP GLN TRP ASP CYS LEU ILE GLU
SEQRES  29 A  383  GLY ASP ASP GLU ASN LEU ILE PRO GLY THR ASN ILE ASN
SEQRES  30 A  383  THR THR ASN GLN HIS ILE
SEQRES   1 B  383  ALA ALA ALA SER PHE GLY GLN THR LYS ILE PRO ARG GLY
SEQRES   2 B  383  ASN GLY PRO TYR SER VAL GLY CYS THR ASP LEU MET PHE
SEQRES   3 B  383  ASP HIS THR ASN LYS GLY THR PHE LEU ARG LEU TYR TYR
SEQRES   4 B  383  PRO SER GLN ASP ASN ASP ARG LEU ASP THR LEU TRP ILE
SEQRES   5 B  383  PRO ASN LYS GLU TYR PHE TRP GLY LEU SER LYS PHE LEU
SEQRES   6 B  383  GLY THR HIS TRP LEU MET GLY ASN ILE LEU ARG LEU LEU
SEQRES   7 B  383  PHE GLY SER MET THR THR PRO ALA ASN TRP ASN SER PRO
SEQRES   8 B  383  LEU ARG PRO GLY GLU LYS TYR PRO LEU VAL VAL PHE SER
SEQRES   9 B  383  HIS GLY LEU GLY ALA PHE ARG THR LEU TYR SER ALA ILE
SEQRES  10 B  383  GLY ILE ASP LEU ALA SER HIS GLY PHE ILE VAL ALA ALA
SEQRES  11 B  383  VAL GLU HIS ARG ASP ARG SER ALA SER ALA THR TYR TYR
SEQRES  12 B  383  PHE LYS ASP GLN SER ALA ALA GLU ILE GLY ASP LYS SER
SEQRES  13 B  383  TRP LEU TYR LEU ARG THR LEU LYS GLN GLU GLU GLU THR
SEQRES  14 B  383  HIS ILE ARG ASN GLU GLN VAL ARG GLN ARG ALA LYS GLU
SEQRES  15 B  383  CYS SER GLN ALA LEU SER LEU ILE LEU ASP ILE ASP HIS
SEQRES  16 B  383  GLY LYS PRO VAL LYS ASN ALA LEU ASP LEU LYS PHE ASP
SEQRES  17 B  383  MET GLU GLN LEU LYS ASP SER ILE ASP ARG GLU LYS ILE
SEQRES  18 B  383  ALA VAL ILE GLY HIS SER PHE GLY GLY ALA THR VAL ILE
SEQRES  19 B  383  GLN THR LEU SER GLU ASP GLN ARG PHE ARG CYS GLY ILE
SEQRES  20 B  383  ALA LEU ASP ALA TRP MET PHE PRO LEU GLY ASP GLU VAL
SEQRES  21 B  383  TYR SER ARG ILE PRO GLN PRO LEU PHE PHE ILE ASN SER
SEQRES  22 B  383  GLU TYR PHE GLN TYR PRO ALA ASN ILE ILE LYS MET LYS
SEQRES  23 B  383  LYS CYS TYR SER PRO ASP LYS GLU ARG LYS MET ILE THR
SEQRES  24 B  383  ILE ARG GLY SER VAL HIS GLN ASN PHE ALA ASP PHE THR
SEQRES  25 B  383  PHE ALA THR GLY LYS ILE ILE GLY HIS MET LEU LYS LEU
SEQRES  26 B  383  LYS GLY ASP ILE ASP SER ASN VAL ALA ILE ASP LEU SER
SEQRES  27 B  383  ASN LYS ALA SER LEU ALA PHE LEU GLN LYS HIS LEU GLY
SEQRES  28 B  383  LEU HIS LYS ASP PHE ASP GLN TRP ASP CYS LEU ILE GLU
SEQRES  29 B  383  GLY ASP ASP GLU ASN LEU ILE PRO GLY THR ASN ILE ASN
SEQRES  30 B  383  THR THR ASN GLN HIS ILE
HET    DFP  A 473      10
HET    DFP  B 473      10
HETNAM     DFP DIISOPROPYL PHOSPHONATE
FORMUL   3  DFP    2(C6 H15 O3 P)
FORMUL   5  HOH   *170(H2 O)
HELIX    1   1 ASN A  100  LEU A  111  1                                  12
HELIX    2   2 HIS A  114  GLY A  126  1                                  13
HELIX    3   3 TYR A  160  SER A  169  1                                  10
HELIX    4   4 ASP A  192  GLY A  199  1                                   8
HELIX    5   5 LYS A  210  GLU A  212  5                                   3
HELIX    6   6 GLU A  213  HIS A  241  1                                  29
HELIX    7   7 ASP A  254  LYS A  259  5                                   6
HELIX    8   8 SER A  273  SER A  273  1                                   1
HELIX    9   9 PHE A  274  ASP A  286  1                                  13
HELIX   10  10 GLY A  303  ILE A  310  5                                   8
HELIX   11  11 TYR A  324  LYS A  333  1                                  10
HELIX   12  12 VAL A  350  ALA A  360  5                                  11
HELIX   13  13 GLY A  362  LYS A  370  1                                   9
HELIX   14  14 ASP A  376  GLY A  397  1                                  22
HELIX   15  15 ASP A  401  ILE A  409  5                                   9
HELIX   16  16 ASN B  100  GLY B  112  1                                  13
HELIX   17  17 HIS B  114  GLY B  126  1                                  13
HELIX   18  18 TYR B  160  HIS B  170  1                                  11
HELIX   19  19 ASP B  192  GLY B  199  1                                   8
HELIX   20  20 LYS B  210  GLU B  212  5                                   3
HELIX   21  21 GLU B  213  HIS B  241  1                                  29
HELIX   22  22 ASP B  254  LYS B  259  5                                   6
HELIX   23  23 SER B  273  SER B  273  1                                   1
HELIX   24  24 PHE B  274  ASP B  286  1                                  13
HELIX   25  25 GLU B  305  ARG B  309  5                                   5
HELIX   26  26 TYR B  324  LYS B  333  1                                  10
HELIX   27  27 VAL B  350  ALA B  360  5                                  11
HELIX   28  28 GLY B  362  LEU B  369  1                                   8
HELIX   29  29 ASP B  376  GLY B  397  1                                  22
HELIX   30  30 ASP B  401  GLN B  404  5                                   4
HELIX   31  31 TRP B  405  GLY B  411  1                                   7
SHEET    1   A10 ASN A 133  TRP A 134  0
SHEET    2   A10 SER A  64  PHE A  72  1  N  VAL A  65   O  ASN A 133
SHEET    3   A10 THR A  79  SER A  87 -1  O  TYR A  85   N  GLY A  66
SHEET    4   A10 ILE A 173  VAL A 177 -1  O  ALA A 176   N  ARG A  82
SHEET    5   A10 TYR A 144  SER A 150  1  N  PHE A 149   O  ALA A 175
SHEET    6   A10 ILE A 262  GLY A 271  1  O  ILE A 270   N  VAL A 148
SHEET    7   A10 CYS A 291  LEU A 295  1  O  LEU A 295   N  GLY A 271
SHEET    8   A10 LEU A 314  SER A 319  1  O  PHE A 315   N  ALA A 294
SHEET    9   A10 ARG A 341  ILE A 346  1  O  LYS A 342   N  PHE A 316
SHEET   10   A10 LEU A 416  PRO A 418 -1  O  ILE A 417   N  THR A 345
SHEET    1   B 2 THR A  95  LEU A  96  0
SHEET    2   B 2 THR A 129  THR A 130 -1  O  THR A 130   N  THR A  95
SHEET    1   C 2 ALA A 186  TYR A 189  0
SHEET    2   C 2 SER A 202  TYR A 205 -1  O  SER A 202   N  TYR A 189
SHEET    1   D10 ASN B 133  TRP B 134  0
SHEET    2   D10 SER B  64  PHE B  72  1  N  VAL B  65   O  ASN B 133
SHEET    3   D10 THR B  79  SER B  87 -1  O  SER B  87   N  SER B  64
SHEET    4   D10 ILE B 173  VAL B 177 -1  O  VAL B 174   N  TYR B  84
SHEET    5   D10 TYR B 144  SER B 150  1  N  VAL B 147   O  ALA B 175
SHEET    6   D10 ILE B 262  GLY B 271  1  O  LYS B 266   N  LEU B 146
SHEET    7   D10 CYS B 291  LEU B 295  1  O  LEU B 295   N  GLY B 271
SHEET    8   D10 LEU B 314  SER B 319  1  O  ILE B 317   N  ALA B 294
SHEET    9   D10 ARG B 341  ILE B 346  1  O  ILE B 344   N  ASN B 318
SHEET   10   D10 LEU B 416  PRO B 418 -1  O  ILE B 417   N  THR B 345
SHEET    1   E 2 THR B  95  LEU B  96  0
SHEET    2   E 2 THR B 129  THR B 130 -1  O  THR B 130   N  THR B  95
SHEET    1   F 2 ALA B 186  TYR B 189  0
SHEET    2   F 2 SER B 202  TYR B 205 -1  O  SER B 202   N  TYR B 189
LINK         C   HIS A 272                 N   SER A 273     1555   1555  1.62
LINK         C   SER A 273                 N   PHE A 274     1555   1555  1.62
LINK         C   HIS B 272                 N   SER B 273     1555   1555  1.64
LINK         C   SER B 273                 N   PHE B 274     1555   1555  1.64
LINK         OG  SER A 273                 P   DFP A 473     1555   1555  1.63
LINK         OG  SER B 273                 P   DFP B 473     1555   1555  1.62
CISPEP   1 PHE A   72    ASP A   73          0        -2.76
CISPEP   2 PHE B   72    ASP B   73          0        -5.91
SITE     1 AC1  7 GLY A 152  LEU A 153  HIS A 272  SER A 273
SITE     2 AC1  7 PHE A 274  HIS A 351  GLN A 352
SITE     1 AC2  6 GLY B 152  LEU B 153  SER B 273  PHE B 274
SITE     2 AC2  6 HIS B 351  GLN B 352
CRYST1  116.375   82.400   96.511  90.00 115.64  90.00 C 1 2 1       8
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.008593  0.000000  0.004125        0.00000
SCALE2      0.000000  0.012136  0.000000        0.00000
SCALE3      0.000000  0.000000  0.011493        0.00000
TER    2986      THR A 425
TER    5980      ASN B 426
MASTER      398    0    2   31   28    0    4    6 6168    2   30   60
END